Goldman Sachs Downgrades Kellogg (K) to Sell
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Goldman Sachs downgraded Kellogg (NYSE: K) from Neutral to Sell with a price target of $59.00 (from $64.00) as top-line weakness eats into cost-savings benefits.
Analyst Jason English said, "top-line rejuvenation efforts are falling flat and the portfolio is coming under what we believe is a retail lead SKU rationalization knife." Given sales weakness this makes management expectation of gradual improvement through this year and into next out of reach.
They lower FY14/FY15/FY16 EPS estimates by 4%/6%/6% and stand 3%/6%/6% below consensus.
Shares of Kellogg closed at $66.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- Web.com, Inc. (WEB) PT Raised to $25 at BWS Financial Ahead of 4Q Report
- Carter's (CRI) PT Lowered to $105 at Oppenheimer; Reiterates Outperform
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change, Downgrades, Hot Downgrades
Related EntitiesGoldman Sachs
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!